The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease.

导出 LinkOut

翻译打印收藏纠错

作者： Robert,Ali ^[1] ; Jeremy,Ramdial ^[2] ; Sandra,Algaze ^[3] ; Amer,Beitinjaneh ^[4]

作者单位： Hematology/Medical Oncology Fellow, University of Miami/Miller School of Medicine, Miami, FL 33136, USA. robert.ali@jhsmiami.org. ^[1] Hematology/Medical Oncology Fellow, University of Miami/Miller School of Medicine, Miami, FL 33136, USA. jeremy.ramdial@jhsmiami.org. ^[2] Internal Medicine Residency Program, University of Miami/Miller School of Medicine, Miami, FL 33136, USA. sandra.algaze@jhsmiami.org. ^[3] Associate Professor of Medicine, Stem Cell Transplant and Cellular Therapy Program, Sylvester Comprehensive Cancer Center, University of Miami/Miller School of Medicine; Miami, FL 33136, USA. abeitinjaneh@miami.edu. ^[4]

关键词 ATG GVHD alemtuzumab allogeneic serotherapy thymoglobulin

DOI 10.3390/biomedicines5040067

PMID 29186076

发布时间 2022-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

Biomedicines

2017年5卷4期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease.

Biomedicines

相似文献

Biomedicines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease.

Biomedicines

相似文献

Biomedicines

相关期刊

检索历史清除